𝔖 Bobbio Scriptorium
✦   LIBER   ✦

ASH 2011—Hodgkin’s disease and the high grade lymphomas

✍ Scribed by Willenbacher, Wolfgang; Willenbacher, Ella

Book ID
118824712
Publisher
Springer-Verlag
Year
2012
Tongue
English
Weight
416 KB
Volume
5
Category
Article
ISSN
1865-5041

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ifosfamide and mitoxantrone (I-M) in rel
Ifosfamide and mitoxantrone (I-M) in relapsed and refractory high grade non-Hodgkin's lymphoma and Hodgkin's disease
✍ G. J. Dovey; Dr. J. A. Child; A. V. Simmons; D. L. Barnard; L. Parapia; M. Morga 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 693 KB

Fifty-five patients, initially diagnosed as having advanced high grade non-Hodgkin's lymphoma (NHL) or Hodgkin's disease (HD) refractory to first-line treatment or in relapse, were treated with ifosfamide 6 g/m', infused over 48 h, followed by mitoxantrone 12 mg/m2. The regimen repeated at three-wee

Ifosfamide in the treatment of high-grad
Ifosfamide in the treatment of high-grade recurrent non-hodgkin's lymphomas
✍ Ian Magrath; Melissa Adde; John Sandlund; Vinay Jain 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 491 KB 👁 1 views

We report the results of two phase I1 trials of ifosfamide in very high risk patients with either partially responsive or recurrent non-Hodgkin's lymphomas. In the first study, in which patients were extremely heavily pretreated (50 per cent had received a very intensive salvage regimen containing v

Twin-track studies of ifosfamide and mit
Twin-track studies of ifosfamide and mitoxantrone (I-M) in recurrent high grade non-hodgkin's lymphoma and hodgkin's disease
✍ Dr J. A. Child; A. V. Simmons; D. L. Barnard; L. Parapia; M. Morgan; R. J. Grace 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 731 KB

Fifty-seven patients, initially diagnosed as having advanced high grade non-Hodgkin's lymphoma (NHL) or Hodgkin's disease (HD) refractory to first-line treatment or in relapse, were treated with ifosfamide 6 g/m2, infused over 48 h, followed by mitoxantrone 12 mg/m2. The regimen repeated at three-we